by Erik Valent | Aug 31, 2021 | Uncategorized
We are pleased to share the first published paper from the MMpredict project, titled: Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials ....
by Erik Valent | Jul 8, 2021 | Uncategorized
This video is the result of the collaborative MMpredict initiative dedicated to develop a personalised medicine tool that predicts the most effective treatment strategy for individual Multiple Myeloma patients. In this video a myeloma expert from the US, Dr. Usmani...
by Erik Valent | Apr 6, 2021 | Uncategorized
Multiple myeloma is caused by the abnormal proliferation of plasma cells which produce antibodies as part of the organism’s natural defence. Although treatment options have expanded over the years, it remains incurable, and patients often receive multiple treatments...
by Erik Valent | Jan 6, 2021 | Uncategorized
Summary of the context and overall objectives of the project The Horizon 2020 MMpredict initiative was started on November 1st 2016 and included the following consortium partners: SkylineDx, the Department of Haematology of the Erasmus University Medical Centre...
by Erik Valent | Nov 2, 2020 | Uncategorized
After more than 4 years of research, the H2020-funded MMpredict project is successfully implemented and officially concluded as of November 1st, 2020. However, research in the field of multiple myeloma should never stop. Therefore we’ll host a subsequent...
